Trial
NCT02618577
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
Atrial Fibrillation Network
Collaborators
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Condition
Atrial High Rate Episodes
Intervention
Edoxaban
Why stopped
following a recommendation from the data safety and monitoring board due to safety concerns and a tendency towards futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-06